Acadia Healthcare Company, Inc. $ACHC Stock Position Lifted by Congress Asset Management Co.

Key Points

• Congress Asset Management Co. increased its Acadia Healthcare stake by 20.8% in the third quarter, bringing its holdings to 287,390 shares valued at approximately $7.9 million.
• Analyst views remain mixed: eight analysts rate ACHC a Buy, five a Hold, and two a Sell. The stock has a consensus rating of Hold and an average price target of $30.69.
• Acadia exceeded quarterly expectations with earnings of $0.38 per share versus the $0.35 consensus and revenue of $865.84 million, though revenue declined slightly year over year and the company reported a negative net margin.

Congress Asset Management Co. boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 20.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 287,390 shares of the company's stock after acquiring an additional 49,418 shares during the quarter. Congress Asset Management Co. owned 0.31% of Acadia Healthcare worth $7,903,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. purchased a new stake in Acadia Healthcare during the 2nd quarter valued at $441,685,000. Jefferies Financial Group Inc. bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $106,458,000. Invenomic Capital Management LP lifted its stake in Acadia Healthcare by 71.0% in the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company's stock worth $46,998,000 after acquiring an additional 1,375,647 shares during the period. Vaughan Nelson Investment Management L.P. bought a new stake in Acadia Healthcare in the first quarter valued at $43,017,000. Finally, First Trust Advisors LP boosted its holdings in Acadia Healthcare by 73.0% in the first quarter. First Trust Advisors LP now owns 1,689,442 shares of the company's stock valued at $39,516,000 after acquiring an additional 712,852 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Guggenheim lifted their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 30th. Leerink Partners increased their price target on shares of Acadia Healthcare from $30.00 to $33.00 and gave the stock a "market perform" rating in a research note on Wednesday, September 23rd. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Barclays upped their target price on Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a report on Thursday, July 30th. Finally, KeyCorp increased their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 14th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $30.69.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $29.23 on Thursday. The stock has a market cap of $2.72 billion, a price-to-earnings ratio of -2.35, a PEG ratio of 9.35 and a beta of 0.63. The firm's 50-day moving average is $28.94 and its 200 day moving average is $27.61. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business's revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a provider of behavioral healthcare services. The company operates a network of psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics that provide care for individuals with mental health conditions, substance use disorders and other behavioral health needs.

Acadia's services are designed for children, adolescents and adults and may include inpatient psychiatric treatment, addiction treatment, residential care, partial hospitalization and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.